A multicentre, multinational, double blind, randomised, parallel group, placebo-controlled study of ethyl-eicosapentaenoate (EPA) in patients with Huntington's disease (HD)
Laxdale Ltd (UK)
Study testing an investigational treatment in Huntington's disease.
Recruitment endedNot specifiedNot specifiedISRCTNTreatment trial
Recruiting in: United KingdomExact site not listed by the study registry.
Preparing a short plain-English summary.
